| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | 10.62% | Susquehanna | $115 → $100 | Maintains | Positive |
| 08/04/2023 | 5.09% | TD Cowen | $86 → $95 | Maintains | Outperform |
| 08/04/2023 | -5.97% | Wells Fargo | $95 → $85 | Maintains | Equal-Weight |
| 08/04/2023 | 27.21% | Mizuho | $130 → $115 | Maintains | Buy |
| 08/04/2023 | 10.62% | Rosenblatt | → $100 | Reiterates | Buy → Buy |
| 08/04/2023 | 10.62% | Needham | → $100 | Reiterates | Buy → Buy |
| 07/26/2023 | 5.09% | Wells Fargo | $75 → $95 | Maintains | Equal-Weight |
| 06/06/2023 | 27.21% | Needham | → $115 | Reiterates | Buy → Buy |
| 05/04/2023 | -11.5% | BMO Capital | $135 → $80 | Maintains | Market Perform |
| 05/04/2023 | 27.21% | Craig-Hallum | $150 → $115 | Maintains | Buy |
| 05/04/2023 | 27.21% | Needham | $165 → $115 | Maintains | Buy |
| 05/04/2023 | 10.62% | Rosenblatt | $160 → $100 | Maintains | Buy |
| 05/04/2023 | -17.04% | Wells Fargo | $105 → $75 | Maintains | Equal-Weight |
| 05/04/2023 | 43.81% | Mizuho | $155 → $130 | Maintains | Buy |
| 05/04/2023 | 10.62% | Keybanc | $140 → $100 | Maintains | Overweight |
| 04/25/2023 | 54.87% | Susquehanna | $145 → $140 | Maintains | Positive |
| 04/24/2023 | 115.71% | Oppenheimer | $185 → $195 | Maintains | Outperform |
| 04/24/2023 | 54.87% | Keybanc | $160 → $140 | Maintains | Overweight |
| 04/11/2023 | 16.15% | Wells Fargo | $125 → $105 | Maintains | Equal-Weight |
| 02/03/2023 | 60.4% | Susquehanna | $115 → $145 | Maintains | Positive |
| 02/03/2023 | 65.93% | Craig-Hallum | $120 → $150 | Maintains | Buy |
| 02/03/2023 | 65.93% | Cowen & Co. | $100 → $150 | Maintains | Outperform |
| 02/03/2023 | 49.34% | BMO Capital | $90 → $135 | Maintains | Market Perform |
| 02/03/2023 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 02/03/2023 | 76.99% | Keybanc | $115 → $160 | Maintains | Overweight |
| 01/27/2023 | 27.21% | Wells Fargo | $90 → $115 | Maintains | Equal-Weight |
| 11/04/2022 | -0.44% | Wells Fargo | $100 → $90 | Maintains | Equal-Weight |
| 11/04/2022 | -0.44% | BMO Capital | $110 → $90 | Maintains | Market Perform |
| 11/04/2022 | 76.99% | Mizuho | $205 → $160 | Maintains | Buy |
| 11/04/2022 | 43.81% | Needham | $140 → $130 | Maintains | Buy |
| 11/04/2022 | 27.21% | Keybanc | $130 → $115 | Maintains | Overweight |
| 10/31/2022 | 21.68% | Cowen & Co. | $210 → $110 | Maintains | Outperform |
| 10/11/2022 | 10.62% | Wells Fargo | $155 → $100 | Maintains | Equal-Weight |
| 09/12/2022 | 104.65% | Needham | $220 → $185 | Maintains | Buy |
| 08/08/2022 | 110.18% | Oppenheimer | $230 → $190 | Maintains | Outperform |
| 08/05/2022 | 126.77% | Keybanc | $215 → $205 | Maintains | Overweight |
| 08/05/2022 | 126.77% | Mizuho | $225 → $205 | Maintains | Buy |
| 07/12/2022 | 137.83% | Keybanc | $250 → $215 | Maintains | Overweight |
| 07/11/2022 | 38.27% | Wells Fargo | $175 → $125 | Maintains | Equal-Weight |
| 05/06/2022 | 148.89% | Mizuho | $250 → $225 | Maintains | Buy |
| 05/06/2022 | 253.98% | Rosenblatt | $345 → $320 | Maintains | Buy |
| 05/06/2022 | 193.14% | Needham | $340 → $265 | Maintains | Buy |
| 04/18/2022 | 176.55% | Mizuho | $290 → $250 | Maintains | Buy |
| 04/12/2022 | 176.55% | Keybanc | $310 → $250 | Maintains | Overweight |
| 04/07/2022 | 104.65% | Wells Fargo | → $185 | Initiates Coverage On | → Equal-Weight |
| 02/04/2022 | 276.11% | Needham | $320 → $340 | Maintains | Buy |
| 12/31/2021 | 281.64% | Rosenblatt | $290 → $345 | Maintains | Buy |
| 12/15/2021 | 253.98% | Needham | $300 → $320 | Maintains | Buy |
| 12/14/2021 | 253.98% | Susquehanna | $275 → $320 | Maintains | Positive |
| 11/30/2021 | 242.92% | Keybanc | $270 → $310 | Maintains | Overweight |
| 11/08/2021 | 215.27% | Oppenheimer | $165 → $285 | Maintains | Outperform |
| 11/05/2021 | — | Summit Insights Group | Upgrades | Hold → Buy | |
| 11/05/2021 | 231.86% | Needham | $220 → $300 | Maintains | Buy |
| 11/05/2021 | 176.55% | Mizuho | $195 → $250 | Maintains | Buy |
| 11/05/2021 | 198.67% | Keybanc | $230 → $270 | Maintains | Overweight |
| 10/05/2021 | 154.42% | Keybanc | $220 → $230 | Maintains | Overweight |
| 08/31/2021 | 121.24% | Cowen & Co. | $176 → $200 | Maintains | Outperform |
| 08/31/2021 | 121.24% | Rosenblatt | $175 → $200 | Maintains | Buy |
| 08/31/2021 | 143.36% | Keybanc | $190 → $220 | Maintains | Overweight |
| 08/23/2021 | 115.71% | Mizuho | $178 → $195 | Maintains | Buy |
| 08/11/2021 | 93.58% | Arete Research | → $175 | Downgrades | Buy → Neutral |
| 08/06/2021 | 93.58% | Rosenblatt | $165 → $175 | Maintains | Buy |
| 08/06/2021 | 143.36% | Needham | $200 → $220 | Maintains | Buy |
| 08/06/2021 | 110.18% | Keybanc | $170 → $190 | Maintains | Overweight |
| 07/15/2021 | 93.58% | Mizuho | $145 → $175 | Maintains | Buy |
| 07/14/2021 | 88.05% | Keybanc | $160 → $170 | Maintains | Overweight |
| 05/07/2021 | 82.52% | Rosenblatt | $150 → $165 | Maintains | Buy |
| 05/07/2021 | 121.24% | Needham | $180 → $200 | Maintains | Buy |
| 05/07/2021 | 104.65% | Morgan Stanley | $173 → $185 | Maintains | Overweight |
| 05/07/2021 | 76.99% | Keybanc | $145 → $160 | Maintains | Overweight |
| 04/27/2021 | 94.69% | Cowen & Co. | $130 → $176 | Upgrades | Market Perform → Outperform |
| 03/29/2021 | 99.12% | Needham | $150 → $180 | Maintains | Buy |
| 03/10/2021 | 93.58% | JP Morgan | $129 → $175 | Upgrades | Neutral → Overweight |
| 02/24/2021 | 91.37% | Morgan Stanley | → $173 | Initiates Coverage On | → Overweight |
| 02/05/2021 | 65.93% | Rosenblatt | $110 → $150 | Maintains | Buy |
| 02/05/2021 | 65.93% | Needham | $130 → $150 | Maintains | Buy |
| 02/05/2021 | 54.87% | Oppenheimer | → $140 | Upgrades | Perform → Outperform |
| 02/05/2021 | — | Craig-Hallum | Upgrades | Hold → Buy | |
| 02/05/2021 | 60.4% | Keybanc | $120 → $145 | Maintains | Overweight |
| 01/21/2021 | 21.68% | JP Morgan | $73 → $110 | Upgrades | Underweight → Neutral |
| 01/06/2021 | 32.74% | KeyBanc | $100 → $120 | Maintains | Overweight |
| 11/30/2020 | -5.97% | Cowen & Co. | → $85 | Initiates Coverage On | → Market Perform |
| 11/06/2020 | 43.81% | Needham | $120 → $130 | Maintains | Buy |
| 11/06/2020 | 21.68% | Rosenblatt | $95 → $110 | Maintains | Buy |
| 08/06/2020 | -0.44% | BMO Capital | $70 → $90 | Maintains | Market Perform |
| 08/06/2020 | 5.09% | Rosenblatt | $86 → $95 | Maintains | Buy |
| 08/06/2020 | 32.74% | Needham | $100 → $120 | Maintains | Buy |
| 08/06/2020 | 10.62% | Keybanc | → $100 | Upgrades | Sector Weight → Overweight |
| 07/21/2020 | -4.87% | Rosenblatt | $73 → $86 | Maintains | Buy |
| 07/21/2020 | 10.62% | Susquehanna | $68 → $100 | Upgrades | Neutral → Positive |
| 07/08/2020 | -19.25% | Rosenblatt | $66 → $73 | Upgrades | Neutral → Buy |
| 06/15/2020 | -26.99% | Rosenblatt | → $66 | Initiates Coverage On | → Neutral |
| 03/31/2020 | 5.09% | Keybanc | → $95 | Downgrades | Overweight → Sector Weight |
| 03/20/2020 | -55.75% | JP Morgan | $73 → $40 | Downgrades | Neutral → Underweight |
| 02/07/2020 | 10.62% | Needham | $80 → $100 | Maintains | Buy |
| 02/07/2020 | -11.5% | Mizuho | $77 → $80 | Maintains | Buy |
| 02/07/2020 | 5.09% | Keybanc | $80 → $95 | Maintains | Overweight |
| 02/07/2020 | -19.25% | JP Morgan | $52 → $73 | Upgrades | Underweight → Neutral |
| 01/16/2020 | — | Mizuho | Upgrades | Neutral → Buy | |
| 01/03/2020 | -11.5% | Keybanc | → $80 | Upgrades | Sector Weight → Overweight |
| 12/19/2019 | — | Summit Insights Group | Upgrades | Hold → Buy | |
| 12/17/2019 | -50.22% | Rosenblatt | → $45 | Downgrades | Neutral → Sell |
| 11/18/2019 | -55.75% | JP Morgan | $32 → $40 | Maintains | Underperform |
| 11/08/2019 | -64.6% | JP Morgan | $25 → $32 | Maintains | Underweight |
| 08/09/2019 | -63.5% | BMO Capital | $29 → $33 | Maintains | Market Perform |
| 08/09/2019 | -55.75% | Dougherty & Co. | → $40 | Upgrades | Neutral → Buy |
| 08/09/2019 | -72.35% | JP Morgan | $35 → $25 | Downgrades | Neutral → Underweight |
| 08/09/2019 | -55.75% | Dougherty & Co. | → $40 | Upgrades | Neutral → Buy |
| 05/10/2019 | -61.28% | Mizuho | $39 → $35 | Maintains | Neutral |
| 03/19/2019 | -61.28% | BMO Capital | $42 → $35 | Maintains | Market Perform |
| 03/18/2019 | -50.22% | JP Morgan | $50 → $45 | Maintains | Neutral |
| 03/18/2019 | -56.86% | Mizuho | $48 → $39 | Downgrades | Buy → Neutral |
| 02/08/2019 | -44.69% | JP Morgan | $55 → $50 | Downgrades | Overweight → Neutral |
| 12/07/2018 | -57.96% | Susquehanna | → $38 | Initiates Coverage On | → Neutral |
| 11/09/2018 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 08/10/2018 | -39.16% | JP Morgan | $52 → $55 | Maintains | Overweight |
| 08/10/2018 | -51.33% | BMO Capital | $39 → $44 | Maintains | Market Perform |
What is the target price for Synaptics (SYNA)?
The latest price target for Synaptics (NASDAQ: SYNA) was reported by Susquehanna on August 4, 2023. The analyst firm set a price target for $100.00 expecting SYNA to rise to within 12 months (a possible 10.62% upside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Synaptics (SYNA)?
The latest analyst rating for Synaptics (NASDAQ: SYNA) was provided by Susquehanna, and Synaptics maintained their positive rating.
When is the next analyst rating going to be posted or updated for Synaptics (SYNA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Synaptics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Synaptics was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
Is the Analyst Rating Synaptics (SYNA) correct?
While ratings are subjective and will change, the latest Synaptics (SYNA) rating was a maintained with a price target of $115.00 to $100.00. The current price Synaptics (SYNA) is trading at is $90.40, which is out of the analyst's predicted range.